Levy Wealth Management Group’s Global X Funds Global X HealthTech ETF HEAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-5,095
Closed -$155K 108
2024
Q1
$155K Hold
5,095
0.04% 104
2023
Q4
$155K Hold
5,095
0.04% 104
2023
Q3
$140K Buy
5,095
+63
+1% +$2.02K 0.04% 107
2023
Q2
$176K Sell
5,032
-62
-1% -$2.16K 0.05% 108
2023
Q1
$179K Sell
5,094
-63
-1% -$2.26K 0.06% 106
2022
Q4
$179K Hold
5,157
0.06% 93
2022
Q3
$175K Buy
5,157
+183
+4% +$6.8K 0.08% 80
2022
Q2
$172K Buy
+4,974
New +$185K 0.08% 67

Other funds holding HEAL

Levy Wealth Management Group's HEAL Position: Q2 2024 in Review

Levy Wealth Management Group sold out of Global X Funds Global X HealthTech ETF (HEAL) in Q2 2024, closing a stake of 5,095 shares — an estimated $155K sold.

Levy Wealth Management Group first reported a position in HEAL in Q2 2022 and held it in 8 quarters. The position peaked at $179K in Q4 2022. 31 funds tracked by Wall St. Rank hold HEAL as of Q2 2024.

  • Levy Wealth Management Group reported no remaining Global X Funds Global X HealthTech ETF position as of Q2 2024 after selling out during the quarter.
  • Levy Wealth Management Group sold 5,095 Global X Funds Global X HealthTech ETF shares in Q2 2024, an estimated $155K.
  • Levy Wealth Management Group first reported a position in Global X Funds Global X HealthTech ETF in Q2 2022 and held it in 8 quarters.
  • Levy Wealth Management Group's Global X Funds Global X HealthTech ETF position peaked at $179K in Q4 2022.
  • 31 funds tracked by Wall St. Rank held Global X Funds Global X HealthTech ETF as of Q2 2024.

Based on Levy Wealth Management Group's 13F filing for Q2 2024, filed 25 Jul 2024.